University of Pennsylvania
This is a Phase 1/2 study in patients presenting with any solid tumor and/or diseased tissue even benign nodules presumed to be resectable and at risk for recurrence on pre-operative assessment who are considered to be good surgical candidates to evaluate the safety and efficacy of the image-guided surgery using indocyanine green for intramolecular imaging of solid tumors.
Tumor, Solid
Indocyanine Green
PHASE1
PHASE2
Study Type : | INTERVENTIONAL |
Estimated Enrollment : | 500 participants |
Masking : | NONE |
Primary Purpose : | DIAGNOSTIC |
Official Title : | A Study to Evaluate the Safety and Efficacy of Indocyanine Green for Intraoperative Molecular Imaging of Solid Tumors (TumorGlow™) |
Actual Study Start Date : | 2024-08-14 |
Estimated Primary Completion Date : | 2026-01-14 |
Estimated Study Completion Date : | 2026-01-14 |
Information not available for Arms and Intervention/treatment
Ages Eligible for Study: | 18 Years |
Sexes Eligible for Study: | ALL |
Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
RECRUITING
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104